drugset / Trial / NCT00458419

Role of Endorphins in the Perception of Dyspnea in Patients With Chronic Obstructive Pulmonary Disease

NCT00458419

Completed 17 enrolled Dartmouth-Hitchcock Medical Center
RandomizedCrossoverTriple-blindDiagnostic

Summary

Endorphins are naturally occurring narcotic substances that are released when individuals perform exercise. The hypothesis of the study is that endorphins reduce the severity of breathlessness during exercise in patients with chronic obstructive pulmonary disease (COPD). The initial five visits include familiarization and validation of a computerized system for patients to report dyspnea and leg discomfort continuously during exercise testing. At Visits 6 and 7 blood is drawn to measure serum endorphin levels pre-exercise, end exercise, and 30 minutes after exercise. Normal saline or naloxone is given intravenously 5 minutes prior to exercise in a double-blinded design. The primary outcome is the slope of oxygen consumption - dyspnea.

Timeline

Start
2005-09
Primary completion
Completion
2007-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Naloxone Small molecule 10 mg Intravenous